Percutaneous transvenous mitral commissurotomy in 390 cases using the Inoue balloon catheter.
Percutaneous transvenous mitral commissurotomy using the Inoue technique was performed in 390 cases of rheumatic mitral stenosis. There were 220 (56%) females and 170 (44%) males. The age range was 9-47 years [mean +/- S.D., 26 +/- 14) and all were symptomatic (New York Heart Association (NYHA) class II in 23 (6%); class III in 280 (72%); and class IV in 87 (22%) patients]. Mitral valve area increased from 0.6 +/- 0.4 to 2 +/- 0.7 cm2, mean transmitral gradients decreased from 26 +/- 8 to 5 +/- 3 mmHg and cardiac index improved from 2.2 +/- 0.8 to 3.0 +/- 0.7 l/min/m2 (P < 0.001). There were no procedure related deaths. An increase in mitral regurgitation by one grade was observed in 40 (10%) cases, with 8 (2%) cases developing severe mitral regurgitation. Oximetry evidence of left to right atrial shunt (Qp/Qs > or = 1.5:1) was observed in 11 (3%) patients. Four (1.0%) patients developed cardiac tamponade, none had thromboembolism. Follow-up of 290 cases at 26 +/- 5 weeks showed persistent improvement in clinical (NYHA class I in 98%) and echocardiographic mitral valve area. Percutaneous transvenous mitral commissurotomy is safe, easy to perform and provides excellent clinical and hemodynamic benefit in the majority of cases.
Bahl
V K
VK
Department of Cardiology, All India Institute of Medical Sciences, New Delhi.
Chandra
S
S
Talwar
K K
KK
Kaul
U
U
Sharma
S
S
Wasir
H S
HS
D000328:Adult; D021721:Balloon Occlusion; D002404:Catheterization / Q000295:instrumentation* / Q000706:statistics & numerical data; D005260:Female; D005500:Follow-Up Studies; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D007194:India / Q000453:epidemiology; D008297:Male; D008946:Mitral Valve Stenosis / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D012214:Rheumatic Heart Disease / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D013997:Time Factors